Skip Navigation

European Heart Journal 2002 23(14):1078-1080; doi:10.1053/euhj.2001.3183
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kalra, P.R.
Right arrow Articles by Anker, S.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalra, P.R.
Right arrow Articles by Anker, S.D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Sympathetic activation and malignant ventricular arrhythmias: a molecular link?

P.R. Kalraa, P.P. Ponikowskib and S.D. Ankera,c

a Clinical Cardiology, National Heart and Lung Institute, London, U.K.
b Cardiology Department, Military Hospital, Wroclaw, Poland
c Department of Cardiology, Charité, Campus Berlin-Buch, Max Delbrück Centrum for Molecular Medicine, Berlin, Germany

References

  1. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation. 1988;77:721–730[Free Full Text]
  2. Cohn J, Levine TB, Olivari MT. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819–823[Abstract]
  3. Anker SD. Catecholamine levels and treatment in chronic heart failure. Eur Heart J. 1998;19:F56–51
  4. Anker SD, Ponikowski P, Varney S. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050–1053[CrossRef][ISI][Medline]
  5. Anker SD, Chua TP, Ponikowski P. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997;96:526–534[Abstract/Free Full Text]
  6. Ponikowski P, Chua TP, Piepoli M. Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation. 1997;96:2586–2594[Abstract/Free Full Text]
  7. Parati G, Saul JP, DiRienzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation: a critical appraisal. Hypertension. 1995;25:1276–1286[Abstract/Free Full Text]
  8. Brunner-La Rocca HP, Esler MD, Jennings GL, Kaye DM. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J. 2001;22:1136–1143[Abstract/Free Full Text]
  9. Schillinger W, Schneider H, Minami K, Ferrari R, Hasenfuss G. Importance of sympathetic activation for the expression of Na+-Ca2+ exchanger in end-stage failing human myocardium. Eur Heart J. 2002;23:1118–1124[Abstract/Free Full Text]
  10. Uretsky BF, Thygesen K, Armstrong PW. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation. 2000;102:611–616[Abstract/Free Full Text]
  11. Colucci WS, Elkayam U, Horton DP. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med. 2000;343:246–253[Abstract/Free Full Text]
  12. Burger AJ, Elkayam U, Neibaur M. Comparison of the occurrence of ventricular arrythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy. Am J Cardiol. 2001;88:35–39[ISI][Medline]
  13. Kalra PR, Anker SD, Struthers AD, Coats AJ. The role of C-type natriuretic peptide in cardiovascular medicine. Eur Heart J. 2001;22:997–1007[Free Full Text]
  14. Anker SD, Coats AJS. Metabolic, functional, and haemodynamic staging for CHF? Lancet. 1996;348:1530–1531[CrossRef][ISI][Medline]
  15. Mancini D, LeJemtel T, Aaronson K. Peak VO(2): a simple yet enduring standard. Circulation. 2000;101:1080–1082[Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kalra, P.R.
Right arrow Articles by Anker, S.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalra, P.R.
Right arrow Articles by Anker, S.D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?